Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

NCT07115810 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.

NCT NCT07115810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
Lead sponsor
King Faisal Specialist Hospital & Research Center
Phase
Observational
Overall status
Completed
Start date
January 1, 1988
Completion date
December 31, 2024
Enrollment
178 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

differentiated thyroid cancer